BridgeBio Pharma Inc. (NASDAQ: BBIO) shares surged Monday morning after the company announced positive results in its achondroplasia trial.The biopharmaceutical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE